Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Diflunisal in HIV-infected Adults
NCT01676363Phase 4Terminated
- Sponsor
- University of British Columbia
- Start
- Mar 2013
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of diflunisal in human immunodeficiency virus infection (HIV), sponsored by University of British Columbia. Started Mar 2013; status: terminated.
02
Drugs
diflunisal
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01676363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01676363.